Group II GBCM Can Be Used Safely for Imaging in Stage 4/5 CKD Patients: COMMENTARY
Author:
Publisher
American Society of Nephrology (ASN)
Subject
General Medicine
Reference14 articles.
1. American College of Radiology Committee on Drugs and Contrast Media: Nephrogenic systemic fibrosis (NSF). In: ACR Manual on Contrast Media, Reston, VA, American College of Radiology, 2020, pp 83–91. Available at: https://www.acr.org/-/media/ACR/Files/Clinical-Resources/Contrast_Media.pdf. Accessed October 4, 2020
2. Nephrogenic Systemic Fibrosis and Gadolinium-Based Contrast Agents
3. Nephrogenic Systemic Fibrosis Risk Assessment and Skin Biopsy Quantification in Patients with Renal Disease following Gadobenate Contrast Administration
4. Observational study on the incidence of nephrogenic systemic fibrosis in patients with renal impairment following gadoterate meglumine administration: the NSsaFe study.
5. Risk of nephrogenic systemic fibrosis in patients with stage 4 or 5 chronic kidney disease receiving a group II gadolinium‐based contrast agent: A systematic review and meta‐analysis;Woolen;JAMA Intern Med,2020
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3